{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:43:39Z","timestamp":1793573019616,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.semnephrol.2023.151470","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:19:41Z","timestamp":1705742381000},"page":"151470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["HIV and Associated TB: A Lethal Association for Kidney Health?"],"prefix":"10.1016","volume":"43","author":[{"given":"Robert","family":"Kalyesubula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Wearne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2023.151470_bib0001","author":"Reeves","year":"1992"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0002","series-title":"The Top 10 Causes of Death","year":"2020"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0003","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/j.ajkd.2012.04.034","article-title":"The evolution of our knowledge of HIV-associated kidney disease in Africa","volume":"60","author":"Swanepoel","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0004","series-title":"HIV and AIDS","year":"2023"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0005","series-title":"Tuberculosis","year":"2023"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0006","unstructured":"WHO. The End TB Strategy. World Health Organization; 2015."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0007","series-title":"In Danger: UNAIDS Global AIDS Update 2022","year":"2022"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0008","series-title":"Global Tuberculosis Report 2021: Supplementary Material","year":"2022"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0009","unstructured":"WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. World Health Organisation."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection","volume":"16","author":"Bell","year":"2018","journal-title":"Nat Rev Microbiol."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/QAD.0000000000002204","article-title":"Kidney disease in Africans with HIV and tuberculosis","volume":"33","author":"Wearne","year":"2019","journal-title":"AIDS."},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151470_bib0012","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.ekir.2020.06.036","article-title":"Predictors and prognosis of HIV-associated nephropathy on kidney biopsy in South Africa","volume":"5","author":"Bookholane","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269260","article-title":"Clinicopathological correlation of kidney disease in HIV infection pre- and post-ART rollout","volume":"17","author":"Diana","year":"2022","journal-title":"PLoS One."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0014","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-11-1","article-title":"HIV, drugs and the kidney","volume":"9","author":"Wearne","year":"2020","journal-title":"Drugs Context."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ekir.2023.02.1076","article-title":"The evolving spectrum of kidney histology in HIV-positive patients in South Africa","volume":"8","author":"Wearne","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0016","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.kint.2020.01.018","article-title":"The spectrum of kidney biopsy findings in HIV-infected patients in the modern era","volume":"97","author":"Kudose","year":"2020","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0017","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1468-1293.2001.00079.x","article-title":"Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai","volume":"2","author":"Lanjewar","year":"2001","journal-title":"HIV Med."},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151470_bib0018","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0344-0338(98)80046-0","article-title":"AIDS-associated nephropathy: 5-year retrospective morphologic analysis of 87 cases","volume":"194","author":"Soriano-Rosas","year":"1998","journal-title":"Pathol Res Pract."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0019","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/nep.13564","article-title":"Granulomatous interstitial nephritis on renal biopsy in human immunodeficiency virus positive patients: prevalence and causes in Cape Town, South Africa","volume":"24","author":"Davidson","year":"2019","journal-title":"Nephrology (Carlton)."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ekir.2021.12.008","article-title":"Acute interstitial nephritis in tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"7","author":"Do Vale","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151470_bib0021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis."},{"issue":"16","key":"10.1016\/j.semnephrol.2023.151470_bib0022","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/QAD.0000000000000398","article-title":"Renal epithelial cells produce and spread HIV-1 via T-cell contact","volume":"28","author":"Blasi","year":"2014","journal-title":"AIDS."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0023","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/QAD.0000000000002589","article-title":"Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages","volume":"34","author":"Hughes","year":"2020","journal-title":"AIDS."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0024","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/01.ASN.0000019642.55998.69","article-title":"HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes","volume":"13","author":"Husain","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01718-17","article-title":"Polyploidy and mitotic cell death are two distinct HIV-1 Vpr-driven outcomes in renal tubule epithelial cells","volume":"92","author":"Payne","year":"2018","journal-title":"J Virol."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-018-0490-9","article-title":"The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects","volume":"25","author":"Osuji","year":"2018","journal-title":"J Biomed Sci."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1523-1755.1998.00789.x","article-title":"Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes","volume":"53","author":"O'Donnell","year":"1998","journal-title":"Kidney Int."},{"issue":"5993","key":"10.1016\/j.semnephrol.2023.151470_bib0028","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41581-022-00538-3","article-title":"The evolving story of apolipoprotein L1 nephropathy: the end of the beginning","volume":"18","author":"Daneshpajouhnejad","year":"2022","journal-title":"Nat Rev Nephrol."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0031","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0032","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5527\/wjn.v4.i2.295","article-title":"African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era","volume":"4","author":"Kasembeli","year":"2015","journal-title":"World J Nephrol."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0033","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0034","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0036","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","article-title":"Renal epithelium is a previously unrecognized site of HIV-1 infection","volume":"11","author":"Bruggeman","year":"2000","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0037","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm0502-522","article-title":"Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy","volume":"8","author":"Marras","year":"2002","journal-title":"Nat Med."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0038","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2013050564","article-title":"The kidney as a reservoir for HIV-1 after renal transplantation","volume":"25","author":"Canaud","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0039","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJMc1910189","article-title":"Detection of donor's HIV strain in HIV-positive kidney-transplant recipient","volume":"382","author":"Blasi","year":"2020","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-019-0326-9","article-title":"Detection and molecular characterization of urinary tract HIV-1 populations","volume":"18","author":"Mzingwane","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob."},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151470_bib0041","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4065\/82.9.1103","article-title":"HIV-1 infection and the kidney: an evolving challenge in HIV medicine","volume":"82","author":"de Silva","year":"2007","journal-title":"Mayo Clin Proc."},{"issue":"suppl 1)","key":"10.1016\/j.semnephrol.2023.151470_bib0042","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0000000000000259","article-title":"HIV-associated renal and genitourinary comorbidities in Africa","volume":"67(","author":"Kalyesubula","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0043","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/QAD.0000000000002753","article-title":"HIV-1 infection of the kidney: mechanisms and implications","volume":"35","author":"Hughes","year":"2021","journal-title":"AIDS."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0044","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12916-022-02639-z","article-title":"Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018","volume":"20","author":"Haeuser","year":"2022","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0045","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12877-022-03720-1","article-title":"Association of phenotypic aging marker with comorbidities, frailty and inflammatory markers in people living with HIV","volume":"22","author":"Han","year":"2022","journal-title":"BMC Geriatr."},{"issue":"663","key":"10.1016\/j.semnephrol.2023.151470_bib0046","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/pgmj.57.663.31","article-title":"Pattern of renal amyloidosis in Indian patients","volume":"57","author":"Chugh","year":"1981","journal-title":"Postgrad Med J."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0047","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","article-title":"Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0048","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis","volume":"10","author":"Muller","year":"2010","journal-title":"Lancet Infect Dis."},{"issue":"13","key":"10.1016\/j.semnephrol.2023.151470_bib0049","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5414\/CNP86S117","article-title":"HIV-associated renal disease - an overview","volume":"86","author":"Wearne","year":"2016","journal-title":"Clin Nephrol. 2016;"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0050","doi-asserted-by":"crossref","first-page":"e1355","DOI":"10.1002\/cti2.1355","article-title":"Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis","volume":"10","author":"McLean","year":"2021","journal-title":"Clin Transl Immunol."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0051","article-title":"Nephrotoxicity of HAART","volume":"2011","author":"Kalyesubula","year":"2011","journal-title":"AIDS Res Treat."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0052","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.kint.2022.06.021","article-title":"HIV at 40: kidney disease in HIV treatment, prevention, and cure","volume":"102","author":"Lucas","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0053","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/ajkd.1998.v31.pm9428460","article-title":"Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features","volume":"31","author":"De Vriese","year":"1998","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0054","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40121-023-00761-w","article-title":"Incidence of and risk factors for acute kidney injury during antituberculosis treatment: a prospective cohort study and literature review","volume":"12","author":"Chang","year":"2023","journal-title":"Infect Dis Ther."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/nep.13399","article-title":"Expression profile of markers of oxidative stress, injury and apoptosis in anti-tuberculosis drugs induced nephrotoxicity","volume":"24","author":"Sharma","year":"2019","journal-title":"Nephrology (Carlton)."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0056","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ckj\/sfu008","article-title":"HIV medication-based urolithiasis","volume":"7","author":"Izzedine","year":"2014","journal-title":"Clin Kidney J."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0057","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0058","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.2009.14","article-title":"Tenofovir renal toxicity targets mitochondria of renal proximal tubules","volume":"89","author":"Kohler","year":"2009","journal-title":"Lab Invest."},{"issue":"1-2","key":"10.1016\/j.semnephrol.2023.151470_bib0059","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2007.02.036","article-title":"Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor","volume":"339","author":"Agarwal","year":"2007","journal-title":"Int J Pharm."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0060","first-page":"434","article-title":"Renal effects of novel antiretroviral drugs","volume":"32","author":"Milburn","year":"2017","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151470_bib0061","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.5588\/ijtld.18.0626","article-title":"Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia","volume":"23","author":"Buziashvili","year":"2019","journal-title":"Int J Tuberc Lung Dis."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0062","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0094-0143(02)00123-4","article-title":"Genitourinary manifestations of tuberculosis","volume":"30","author":"Wise","year":"2003","journal-title":"Urol Clin North Am."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0063","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/1008-682X.150839","article-title":"Renal tuberculosis tends to be low symptoms: how to improve the diagnosis and treatment of renal tuberculosis","volume":"18","author":"Wang","year":"2016","journal-title":"Asian J Androl."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0064","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/0970-1591.42626","article-title":"Clinical presentation and diagnostic approach in cases of genitourinary tuberculosis","volume":"24","author":"Kapoor","year":"2008","journal-title":"Indian J Urol."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ckj\/sfv071","article-title":"Etiological diagnosis of granulomatous tubulointerstitial nephritis in the tropics","volume":"8","author":"Agrawal","year":"2015","journal-title":"Clin Kidney J."},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151470_bib0066","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1442-2042.2008.02099.x","article-title":"Epidemiology of urogenital tuberculosis worldwide","volume":"15","author":"Figueiredo","year":"2008","journal-title":"Int J Urol."},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151470_bib0067","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1756287215592604","article-title":"Diseases masking and delaying the diagnosis of urogenital tuberculosis","volume":"7","author":"Kulchavenya","year":"2015","journal-title":"Ther Adv Urol."},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151470_bib0068","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41585-019-0228-9","article-title":"Urogenital tuberculosis - epidemiology, pathogenesis and clinical features","volume":"16","author":"Muneer","year":"2019","journal-title":"Nat Rev Urol."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0069","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11255-008-9436-6","article-title":"Urogenital tuberculosis in immunocompromised patients","volume":"41","author":"Figueiredo","year":"2009","journal-title":"Int Urol Nephrol."},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151470_bib0070","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1261307","article-title":"Tuberculosis and the kidney","volume":"12","author":"Eastwood","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0071","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol."},{"issue":"15","key":"10.1016\/j.semnephrol.2023.151470_bib0072","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0073","first-page":"e19972","article-title":"A case report of renal tuberculosis with associated unusual pulmonary findings","volume":"13","author":"Almazloum","year":"2021","journal-title":"Cureus."},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151470_bib0074","first-page":"1226","article-title":"The diagnosis and misdiagnosis of tuberculosis","volume":"12","author":"Davies","year":"2008","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijid.2018.07.007","article-title":"Detection of Mycobacterium tuberculosis in urine by Xpert MTB\/RIF Ultra: a useful adjunctive diagnostic tool in HIV-associated tuberculosis","volume":"75","author":"Atherton","year":"2018","journal-title":"Int J Infect Dis."},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151470_bib0076","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00005792-199111000-00004","article-title":"Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection","volume":"70","author":"Shafer","year":"1991","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151470_bib0077","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MCP.0b013e328337f23a","article-title":"Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments","volume":"16","author":"Peter","year":"2010","journal-title":"Curr Opin Pulm Med."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0078","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00812-17","article-title":"The new Xpert MTB\/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0079","article-title":"Xpert MTB\/RIF Ultra and Xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults","volume":"1","author":"Kohli","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123323","article-title":"Is urinary lipoarabinomannan the result of renal tuberculosis? Assessment of the renal histology in an autopsy cohort of Ugandan HIV-infected adults","volume":"10","author":"Cox","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0082","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12916-016-0603-9","article-title":"Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Gupta-Wright","year":"2016","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151470_bib0083","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/cid\/ciaa024","article-title":"\"SILVAMP TB LAM\" rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South Africa","volume":"71","author":"Sossen","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0084","unstructured":"World Health Organization, Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy. Updated 2019. Accessed January 18, 2024 https:\/\/www.who.int\/publications\/i\/item\/9789241550604, WHO,2019."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0085","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4102\/sajhivmed.v22i1.1226","article-title":"Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha","volume":"22","author":"Sossen","year":"2021","journal-title":"South Afr J HIV Med."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0086","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/UA.UA_121_19","article-title":"Spectrum of tuberculosis in urology: case series and review of the literature","volume":"12","author":"Ponnayyan","year":"2020","journal-title":"Urol Ann."},{"issue":"41","key":"10.1016\/j.semnephrol.2023.151470_bib0087","doi-asserted-by":"crossref","first-page":"e5146","DOI":"10.1097\/MD.0000000000005146","article-title":"The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: meta-analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0088","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/IJNRD.S93887","article-title":"Update on current management of chronic kidney disease in patients with HIV infection","volume":"9","author":"Diana","year":"2016","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0089","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0090","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12879-019-4010-7","article-title":"Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease","volume":"19","author":"Saito","year":"2019","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0091","article-title":"Treatment of tuberculosis in renal disease in adults","author":"Carroll","year":"2023","journal-title":"Queensland Health"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0092","series-title":"The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance","first-page":"54","year":"2013"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0093","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1164\/ajrccm.159.5.9810034","article-title":"The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol","volume":"159","author":"Malone","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0094","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/089686080302300409","article-title":"Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin","volume":"23","author":"Ahn","year":"2003","journal-title":"Perit Dial Int."},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151470_bib0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/bdd.1860","article-title":"Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients","volume":"34","author":"Frassetto","year":"2013","journal-title":"Biopharm Drug Dispos."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0096","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation\u2013results at 3 to 5 years","volume":"372","author":"Muller","year":"2015","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151470_bib0097","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.ekir.2022.06.013","article-title":"Retrospective review of ART regimens in HIV-positive to HIV-positive kidney transplant recipients","volume":"7","author":"Barday","year":"2022","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0098","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.12688\/f1000research.10414.1","article-title":"Impact of antiretroviral therapy on clinical outcomes in HIV (+) kidney transplant recipients: review of 58 cases","volume":"5","author":"Rosa","year":"2016","journal-title":"F1000Res."},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151470_bib0099","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/TP.0000000000003485","article-title":"Kidney transplantation in HIV-positive patients: current practice and management strategies","volume":"105","author":"Muller","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0100","unstructured":"European AIDS Clinical Society: Solid organ transplantation (SOT) [Internet]. EACS guidelines. accessed athttps:\/\/eacs.sanfordguide.com\/prevention-non-infectious-co-morbidities\/solid-organ-transplant-sot\/solid-organ-transplantation-sot October 2023."},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151470_bib0101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151470_bib0102","doi-asserted-by":"crossref","first-page":"e13949","DOI":"10.1111\/tid.13949","article-title":"Tuberculosis treatment without rifampin in kidney\/kidney-pancreas transplantation: a case series report","volume":"24","author":"Radisic","year":"2022","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0103","article-title":"Table 12. Antiretroviral dosing recommendations in persons with renal or hepatic insufficiency accessed as https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/drug-characteristics-tables-renal-hepatic-insufficiency","year":"2023","journal-title":"National Institutes of Health"},{"key":"10.1016\/j.semnephrol.2023.151470_bib0104","unstructured":"European AIDS Clinical Society: ARV Dosing. Renal impairment [internet]. EACS guidelines accessed athttps:\/\/eacs.sanfordguide.com\/prevention-non-infectious-co-morbidities\/solid-organ-transplant-sot\/solid-organ-transplantation-sot on October 2023."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151470_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.kisu.2017.07.003","article-title":"Reducing major risk factors for chronic kidney disease","volume":"7","author":"Luyckx","year":"2017","journal-title":"Kidney Int Suppl (2011)."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12981-020-00266-3","article-title":"Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV","volume":"17","author":"Heron","year":"2020","journal-title":"AIDS Res Ther."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0107","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jmii.2021.08.011","article-title":"Tuberculosis treatment delay and nosocomial exposure remain important risks for patients undergoing regular hemodialysis","volume":"55","author":"Lu","year":"2022","journal-title":"J Microbiol Immunol Infect."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0108","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12889-015-2331-z","article-title":"HAART, DOTS and renal disease of patients co-infected with HIV\/AIDS and TB in the South West region of Cameroon","volume":"15","author":"Nsagha","year":"2015","journal-title":"BMC Public Health."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151470_bib0109","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/ajt.16205","article-title":"A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action","volume":"21","author":"Durand","year":"2021","journal-title":"Am J Transplant."},{"issue":"89","key":"10.1016\/j.semnephrol.2023.151470_bib0110","first-page":"26464","article-title":"Organ procurement and transplantation: implementation of the HIV Organ Policy Equity Act. Final rule","volume":"80","year":"2015","journal-title":"Fed Regist."},{"key":"10.1016\/j.semnephrol.2023.151470_bib0111","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1022579","article-title":"Chemoprophylaxis for the prevention of tuberculosis in kidney transplant recipients: a systematic review and meta-analysis","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0112","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13104-016-2309-7","article-title":"From antiretroviral therapy access to provision of third line regimens: evidence of HIV drug resistance mutations to first and second line regimens among Ugandan adults","volume":"9","author":"Namakoola","year":"2016","journal-title":"BMC Res Notes."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151470_bib0113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAI.0000000000001883","article-title":"Third-line antiretroviral therapy program in the South African public sector: cohort description and virological outcomes","volume":"80","author":"Moorhouse","year":"2019","journal-title":"J Acquir Immune Defic Syndr."}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T22:22:10Z","timestamp":1748384530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0270929523001808"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151470","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV and Associated TB: A Lethal Association for Kidney Health?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151470"}}